Duchenne Muscular Dystrophy Market Analysis 2023-2032: Market Size, Top Segments, Leading Region Forecast | Bristol Myers Squibb Company, FibroGen Inc., Italfarmaco SpA, NS Pharma Inc., Pfizer Inc., PTC Therapeutics

The Duchenne Muscular Dystrophy Global Market Report 2023, provides comprehensive information on the duchenne muscular dystrophy market across 60+ geographies in the seven regions – Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa for the 27 major global industries. The report covers a ten year historic period – 2010-2021, and a ten year forecast period – 2023-2032.

Learn More On The Duchenne Muscular Dystrophy Market’s Growth:

https://www.thebusinessresearchcompany.com/report/duchenne-muscular-dystrophy-global-market-report

As per The Business Research Company’s Duchenne Muscular Dystrophy Global Market Report 2023, the global duchenne muscular dystrophy market size is expected to grow from $0.98 billion in 2022 to $1.07 billion in 2023 at a compound annual growth rate (CAGR) of 9.2%. The Russia-Ukraine war disrupted the chances of global economic recovery from the COVID-19 pandemic, at least in the short term. The war between these two countries has led to economic sanctions on multiple countries, a surge in commodity prices, and supply chain disruptions, causing inflation across goods and services and affecting many markets across the globe. The global duchenne muscular dystrophy market size is expected to reach $1.48 billion in 2027 at a CAGR of 8.3%.

Get A Free Sample Of The Report (Includes Graphs And Tables):

https://www.thebusinessresearchcompany.com/sample_request?id=10368&type=smp

Technological advancements are a key trend gaining popularity in the Duchenne muscular dystrophy market. Major companies operating in the Duchenne muscular dystrophy market are focusing more on technological advancements and research and development to sustain their position in the market. For instance, in April 2021, according to the University of Texas Southwestern’s s Hamon Center for Regenerative Science and Medicine, a US-based public academic health science center, launched a new type of gene therapy to treat mice with Duchenne muscular dystrophy (DMD) by using CRISPR-Cas9-based techniques to restore a significant portion of the dystrophin protein that is missing in many DMD patients. The scientists created a number of effective CRISPR-Cas9 nucleotide gene editing techniques to bypass the mistaken “stop” signal, restoring the creation of 97 % of the protein. They quickly investigated nucleotide gene editing techniques using cardiomyocytes produced from iPS cells of DMD patients, showing the restoration of the dystrophin protein.

The duchenne muscular dystrophy market is segmented:

1) By Therapy: Mutation Suppression, Exon Skipping Approach

2) By Therapeutic Class: Molecular Based Therapies, Steroid Therapy

3) By Route of Administration: Oral, Parenteral, Other Routes Of Administration

4) By Distribution Channel: Hospital Pharmacy, Online Pharmacy, Retail Pharmacy

5) By End User: Hospitals, Homecare, Specialty Clinics, Other End-Users

North America was the largest region in the duchenne muscular dystrophy market in 2022.

The table of contents in TBRC’s duchenne muscular dystrophy market report includes:

1. Executive Summary
2. Duchenne Muscular Dystrophy Market Characteristics
3. Duchenne Muscular Dystrophy Market Trends And Strategies
4. Duchenne Muscular Dystrophy Market – Macro Economic Scenario
5. Duchenne Muscular Dystrophy Market Size And Growth

.

27. Duchenne Muscular Dystrophy Market Competitive Landscape And Company Profiles
28. Key Mergers And Acquisitions In The Duchenne Muscular Dystrophy Market
29. Duchenne Muscular Dystrophy Market Future Outlook and Potential Analysis
30. Appendix

Learn About Us:
The Business Research Company is a market intelligence firm that pioneers in market, company, and consumer research. TBRC’s specialist consultants are located globally and are experts in a wide range of industries that include healthcare, manufacturing, financial services, chemicals, and technology. The firm has offices located in the UK, the US, and India, along with a network of proficient researchers in 28 countries. Through the report businesses can gain a thorough understanding of the market’s size, growth rate, major drivers and leading players.

Contact Us:
The Business Research Company
Europe: +44 207 1930 708

Asia: +91 88972 63534

Americas: +1 315 623 0293

Email: info@tbrc.info

Follow Us On:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

Twitter: https://twitter.com/tbrc_info

Facebook: https://www.facebook.com/TheBusinessResearchCompany

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Blog: https://blog.tbrc.info/

Healthcare Blog: https://healthcareresearchreports.com/

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model